Home | Structured Search | Drug Resource
Find: within
Posttraumatic Stress Disorder > Consultation for Diagnosis Author: Jeffrey P. Staab, MD, MS
Editorial changes - 2010-01-20
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • The diagnosis of PTSD may not be straightforward and the evaluation may be time consuming.
  • Effective treatment requires a full assessment of PTSD symptoms and potential comorbid disorders.

Evidence:

  • Most patients with chronic PTSD suffer from at least one other psychiatric disorder during their lifetimes. The presence of additional illnesses often determines the specifics of treatment intervention (1; 2; 9).

Comments:

  • None.
FAQs
Jeffrey P. Staab, MD, MS, is a consultant for Eli Lilly, Forest Laboratories, received honorarium from Abbott Laboratories, received grants from GlaxoSmithKline, Pfizer. Michael Roy, MD, editorial consultant, received honorarium from PFizer.
Darren B. Taichman, MD, PhD, Editor, PIER, has received grant support from Actelion Pharmaceuticals Ltd , and honoraria for continuing medical education grand rounds and lectures given.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2010 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.